There is no commercial support for this activity.

About the speaker

Tom lnsel, M.D., a psychiatrist and neuroscientist, has been a national leader in mental health research, policy, and technology.  From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH). More recently (2015 – 2017), he led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA.  In 2017 he co-founded Mindstrong Health, a Silicon Valley start-up building tools for people with serious mental illness.  In 2020, he co-founded Humanest Care, a therapeutic online community for recovery.   Since May of 2019, Dr. Insel has been a special advisor to California Governor Gavin Newsom. Chair of the Board of the Steinberg Institute in Sacramento, California; and serves on the Board of Fountain House.   He is the author of the newly-published book Healing: Our Path from Mental Illness to Mental Health, published by Penguin Random House.  With journalist co-founders, he recently launched MindSite News (www.mindsitenews.org), a non-profit digital publication focused on mental health issues.  Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Thomas R. Insel, MD, reports that he has the following relationships with commercial interests: Dr. Insel is a co-founder of Mindstrong Health, NeuraWell Therapeutics and Humanest Care. He is a shareholder in publicly traded Alphabet, Apple, Compass Pathways, Karuna and Microsoft and holds private equity positions in Alto Neuroscience, Mindstrong Health, NeuraWell Therapeutics, Owl Insights, Uplift and Valera Health. He is a board member of the Foundation for NIH, HealthCare Capital, Schaeffer Center for Health Policy (USC), Valera Health (observer status) and the Steinberg Institute, where he serves as board chair. He is also a member of the scientific advisory boards of Alto Neuroscience, Embodied, Koa Health, NeuraWell Therapeutics, Owl Insights, PsychHub and Cerebral. He will not discuss any products, services, or off-label uses in this presentation.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.